Aberrantly spliced HTT, a new player in Huntington's disease pathogenesis

RNA Biology

Volumn 10, Issue 11, 2013, Pages 1647-1652

  Gipson, Theresa A ^a   Neueder, Andreas ^b   Wexler, Nancy S ^c,d   Bates, Gillian P ^b   Housman, David ^a  

^a MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c Hereditary Disease Foundation   (United States)

^d Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

Htt exon 1; Huntingtin fragment; Huntington's disease; Missplicing; SRSF6

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; DNA; HUNTINGTIN; MESSENGER RNA; RNA BINDING PROTEIN; SMALL NUCLEAR RIBONUCLEOPROTEIN;

3' UNTRANSLATED REGION; 5' UNTRANSLATED REGION; ALTERNATIVE RNA SPLICING; BIOINFORMATICS; BRAIN; CAG REPEAT; ENTROPY; EXON; GC RICH SEQUENCE; GENE EXPRESSION; HUMAN; HUNTINGTON CHOREA; INTRON; NONHUMAN; PATHOGENESIS; POLYADENYLATION; PROTEIN DEGRADATION; PROTEIN MOTIF; REVIEW; RNA INTERFERENCE; RNA SEQUENCE;

HTT EXON 1; HUNTINGTIN FRAGMENT; HUNTINGTON'S DISEASE; MIS-SPLICING; SRSF6;

ANIMALS; HUMANS; HUNTINGTON DISEASE; MUTANT PROTEINS; NERVE TISSUE PROTEINS; NUCLEAR PROTEINS; RNA SPLICING;

EID: 84890402478     PISSN: 15476286     EISSN: 15558584     Source Type: Journal    
DOI: 10.4161/rna.26706     Document Type: Review

References (42)

1. Bates G, Harper PS, Jones L. Huntington's Disease. Oxford University Press; 2002.
2. Cattaneo E, Zuccato C, Tartari M. Normal huntingtin function: an alternative approach to Huntington's disease. Nat Rev Neurosci 2005; 6:919-30; PMID:16288298; http://dx.doi.org/10.1038/nrn1806
3. Altschul SF, Gish W, Miller W, Myers EW, Lipman DJ. Basic local alignment search tool. J Mol Biol 1990; 215:403-10; PMID:2231712; http://dx.doi.org/10. 1016/S0022-2836(05)80360-2
4. Lunkes A, Lindenberg KS, Ben-Haïem L, Weber C, Devys D, Landwehrmeyer GB, Mandel JL, Trottier Y. Proteases acting on mutant huntingtin generate cleaved products that differentially build up cytoplasmic and nuclear inclusions. Mol Cell 2002; 10:259-69; PMID:12191472; http://dx.doi.org/10.1016/ S1097-2765(02)00602-0
5. Landles C, Sathasivam K, Weiss A, Woodman B, Moffitt H, Finkbeiner S, Sun B, Gafni J, Ellerby LM, Trottier Y, et al. Proteolysis of mutant huntingtin produces an exon 1 fragment that accumulates as an aggregated protein in neuronal nuclei in Huntington disease. J Biol Chem 2010; 285:8808-23; PMID:20086007; http://dx.doi.org/10.1074/jbc.M109.075028
6. Sathasivam K, Neueder A, Gipson TA, Landles C, Benjamin AC, Bondulich MK, Smith DL, Faull RL, Roos RA, Howland D, et al. Aberrant splicing of HTT generates the pathogenic exon 1 protein in Huntington disease. Proc Natl Acad Sci U S A 2013; 110:2366-70; PMID:23341618; http://dx.doi.org/10.1073/pnas. 1221891110
7. Zhang MQ. Statistical features of human exons and their flanking regions. Hum Mol Genet 1998; 7:919-32; PMID:9536098; http://dx.doi.org/10.1093/hmg/7.5. 919
8. Yeo G, Burge CB. Maximum entropy modeling of short sequence motifs with applications to RNA splicing signals. J Comput Biol 2004; 11:377-94; PMID:15285897; http://dx.doi.org/10.1089/1066527041410418
9. Xiao X, Wang Z, Jang M, Nutiu R, Wang ET, Burge CB. Splice site strength-dependent activity and genetic buffering by poly-G runs. Nat Struct Mol Biol 2009; 16:1094-100; PMID:19749754; http://dx.doi.org/10.1038/nsmb.1661
10. de Mezer M, Wojciechowska M, Napierala M, Sobczak K, Krzyzosiak WJ. Mutant CAG repeats of Huntingtin transcript fold into hairpins, form nuclear foci and are targets for RNA interference. Nucleic Acids Res 2011; 39:3852-63; PMID:21247881; http://dx.doi.org/10.1093/nar/gkq1323
11. Berg MG, Singh LN, Younis I, Liu Q, Pinto AM, Kaida D, Zhang Z, Cho S, Sherrill-Mix S, Wan L, et al. U1 snRNP determines mRNA length and regulates isoform expression. Cell 2012; 150:53-64; PMID:22770214; http://dx.doi.org/10. 1016/j.cell.2012.05.029
12. Katz Y, Wang ET, Airoldi EM, Burge CB. Analysis and design of RNA sequencing experiments for identifying isoform regulation. Nat Methods 2010; 7:1009-15; PMID:21057496; http://dx.doi.org/10.1038/nmeth.1528
13. Long JC, Caceres JF. The SR protein family of splicing factors: master regulators of gene expression. Biochem J 2009; 417:15-27; PMID:19061484; http://dx.doi.org/10.1042/BJ20081501
14. Tranell A, Fenyö EM, Schwartz S. Serine- and arginine-rich proteins 55 and 75 (SRp55 and SRp75) induce production of HIV-1 vpr mRNA by inhibiting the 52-splice site of exon 3. J Biol Chem 2010; 285:31537-47; PMID:20685659; http://dx.doi.org/10.1074/jbc.M109.077453
15. Labourier EE, Bourbon HMH, Gallouzi IEI, Fostier MM, Allemand EE, Tazi JJ. Antagonism between RSF1 and SR proteins for both splicesite recognition in vitro and Drosophila development. Genes Dev 1999; 13:740-53; http://pubget.com/paper/10090730?inst itut ion=mit.edu; PMID:10090730; http://dx.doi.org/10.1101/gad.13.6.740.
16. Bradnam KR, Korf I. Longer first introns are a general property of eukaryotic gene structure. PLoS One 2008; 3:e3093; PMID:18769727; http://dx.doi.org/10.1371/journal.pone.0003093
17. Gaffney DJ, Keightley PD. Genomic selective constraints in murid noncoding DNA. PLoS Genet 2006; 2:e204; PMID:17166057; http://dx.doi.org/10. 1371/journal.pgen.0020204
18. Gazave E, Marqués-Bonet T, Fernando O, Charlesworth B, Navarro A. Patterns and rates of intron divergence between humans and chimpanzees. Genome Biol 2007; 8:R21; PMID:17309804; http://dx.doi.org/10.1186/gb-2007-8-2-r21
19. Kalari KRK, Casavant MM, Bair TBT, Keen HL, Comeron JM, Casavant TL, Scheetz TE. First exons and introns--a survey of GC content and gene structure in the human genome. In Silico Biol 2006; 6:237-42; PMID:16922687
20. Kriventseva EV, Gelfand MS. Statistical analysis of the exon-intron structure of higher and lower eukaryote genes. J Biomol Struct Dyn 1999; 17:281-8; PMID:10563578; http://dx.doi.org/10.1080/07391102.1999.10508361
21. Marais G, Nouvellet P, Keightley PD, Charlesworth B. Intron size and exon evolution in Drosophila. Genetics 2005; 170:481-5; PMID:15781704; http://dx.doi.org/10.1534/genetics.104.037333
22. Smith MW. Structure of vertebrate genes: a statistical analysis implicating selection. J Mol Evol 1988; 27:45-55; PMID:3133487; http://dx.doi.org/10.1007/BF02099729
23. Zhang Q, Edwards SV. The evolution of intron size in amniotes: a role for powered flight? Genome Biol Evol 2012; 4:1033-43; PMID:22930760; http://dx.doi.org/10.1093/gbe/evs070
24. Jonsson JJ, Foresman MD, Wilson N, McIvor RS. Intron requirement for expression of the human purine nucleoside phosphorylase gene. Nucleic Acids Res 1992; 20:3191-8; PMID:1620616; http://dx.doi.org/10.1093/nar/20.12.3191
25. Palmiter RD, Sandgren EP, Avarbock MR, Allen DD, Brinster RL. Heterologous introns can enhance expression of transgenes in mice. Proc Natl Acad Sci U S A 1991; 88:478-82; PMID:1988947; http://dx.doi.org/10.1073/pnas.88. 2.478
26. Rose AB, Last RL. Introns act post-transcriptionally to increase expression of the Arabidopsis thaliana tryptophan pathway gene PAT1. Plant J 1997; 11:455-64; PMID:9107035; http://dx.doi.org/10.1046/j.1365-313X.1997. 11030455.x
27. Ho SH, So GMK, Chow KL. Postembryonic expression of Caenorhabditis elegans mab-21 and its requirement in sensory ray differentiation. Dev Dyn 2001; 221:422-30; PMID:11500979; http://dx.doi.org/10.1002/dvdy.1161
28. Jeon JS, Lee S, Jung KH, Jun SH, Kim C, An G. Tissue-preferential expression of a rice alpha-tubulin gene, OsTubA1, mediated by the first intron. Plant Physiol 2000; 123:1005-14; PMID:10889249; http://dx.doi.org/10.1104/pp. 123.3.1005
29. Morello LL, Bardini MM, Sala FF, Breviario DD. A long leader intron of the Ostub16 rice beta-tubulin gene is required for high-level gene expression and can autonomously promote transcription both in vivo and in vitro. Plant J 2002; 29:33-44; PMID:12060225; http://dx.doi.org/10.1046/j.0960-7412.2001.01192. x
30. Mascarenhas DD, Mettler IJI, Pierce DAD, Lowe HWH. Intron-mediated enhancement of heterologous gene expression in maize. Plant Mol Biol 1990; 15:913-20; PMID:2103480; http://dx.doi.org/10.1007/BF00039430
31. Rose ABA. Requirements for intron-mediated enhancement of gene expression in Arabidopsis. RNA 2002; 8:1444-53; PMID:12458797; http://dx.doi.org/10.1017/ S1355838202020551
32. Roy M, Kim N, Xing Y, Lee C. The effect of intron length on exon creation ratios during the evolution of mammalian genomes. RNA 2008; 14:2261-73; PMID:18796579; http://dx.doi.org/10.1261/rna.1024908
33. Akerman M, David-Eden H, Pinter RY, Mandel-Gutfreund Y. A computational approach for genomewide mapping of splicing factor binding sites. Genome Biol 2009; 10:R30; PMID:19296853; http://dx.doi.org/10.1186/gb-2009-10-3-r30
34. Cartegni L, Wang J, Zhu Z, Zhang MQ, Krainer AR. ESEfinder: A web resource to identify exonic splicing enhancers. Nucleic Acids Res 2003; 31:3568-71; PMID:12824367; http://dx.doi.org/10.1093/nar/gkg616
35. Han J, Xiong J, Wang D, Fu X-D. Pre-mRNA splicing: where and when in the nucleus. Trends Cell Biol 2011; 21:336-43; PMID:21514162; http://dx.doi.org/10. 1016/j.tcb.2011.03.003
36. Batsché E, Yaniv M, Muchardt C. The human SWI/SNF subunit Brm is a regulator of alternative splicing. Nat Struct Mol Biol 2006; 13:22-9; PMID:16341228; http://dx.doi.org/10.1038/nsmb1030
37. Luco RF, Pan Q, Tominaga K, Blencowe BJ, Pereira-Smith OM, Misteli T. Regulation of alternative splicing by histone modifications. Science 2010; 327:996-1000; PMID:20133523; http://dx.doi.org/10.1126/science.1184208
38. Mangiarini L, Sathasivam K, Seller M, Cozens B, Harper A, Hetherington C, Lawton M, Trottier Y, Lehrach H, Davies SW, et al. Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice. Cell 1996; 87:493-506; PMID:8898202; http://dx.doi.org/10.1016/S0092-8674(00)81369-0
39. DiFiglia M, Sapp E, Chase KO, Davies SW, Bates GP, Vonsattel JP, Aronin N. Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain. Science 1997; 277:1990-3; PMID:9302293; http://dx.doi.org/10. 1126/science.277.5334.1990
40. Lu X-H, Yang XW. "Huntingtin holiday": progress toward an antisense therapy for Huntington's disease. Neuron 2012; 74:964-6; PMID:22726826; http://dx.doi.org/10.1016/j.neuron.2012.06.001
41. Harper SQ. Progress and challenges in RNA interference therapy for Huntington disease. Arch Neurol 2009; 66:933-8; PMID:19667213; http://dx.doi.org/10.1001/archneurol.2009.180
42. Sah DWY, Aronin N. Oligonucleotide therapeutic approaches for Huntington disease. J Clin Invest 2011; 121:500-7; PMID:21285523; http://dx.doi.org/10. 1172/JCI45130